Dataset Information


Audiometric evaluation in individuals with mucopolysaccharidosis.

ABSTRACT: To characterize the audiometric evaluation and acoustic immittance measures in different types of mucopolysaccharidosis. Fifty-three mucopolysaccharidosis patients were evaluated. The classification consisted of type I (Hurler syndrome, Hurler-Scheie and Scheie syndrome), type II (Hunter syndrome), type III (Sanfilippo syndrome), type IV (Morquio syndrome), and type VI (Maroteaux-Lamy syndrome). Immittance audiometry and play or conventional threshold tone audiometry were used to obtain auditory thresholds and were chosen according to the patient's chronological age and ability to understand/respond to the procedure. The findings were analyzed using descriptive statistics and considering the recommendations for research involving human beings contained in Resolution CNE N° 466/2012. Fifty-one subjects (96.2%) had hearing loss, and the conductive type was the most frequent. Only two (3.8%) patients presented bilateral thresholds within normal limits, one with type IV mucopolysaccharidosis and the other with type VI. There were 11 individuals (20.8%) with mucopolysaccharidosis type I with mixed hearing loss, 9 (16.9%) individuals with type I with conductive hearing loss and 9 (16.9%) with type VI with conductive hearing loss. Mild hearing loss was most common (37.3%), followed by moderately severe hearing loss (36.3%). The type B tympanometric curve (80.4%) was the most frequent. Most of the individuals with mucopolysaccharidosis types I, II, III, IV and VI presented mixed or conductive hearing losses of mild to moderately severe degree, type B tympanograms and an absence of contralateral acoustic reflexes.


PROVIDER: S-EPMC6251249 | BioStudies | 2018-01-01T00:00:00Z


REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4189384 | BioStudies
2017-01-01 | S-EPMC5307824 | BioStudies
2020-01-01 | S-EPMC7151028 | BioStudies
2018-10-18 | GSE111906 | GEO
2020-01-01 | S-EPMC6978265 | BioStudies
1000-01-01 | S-EPMC6055821 | BioStudies
2018-01-01 | S-EPMC5975427 | BioStudies
2018-01-01 | S-EPMC6454448 | BioStudies
2011-01-01 | S-EPMC3173625 | BioStudies
2019-01-01 | S-EPMC6899772 | BioStudies